Point of Care Nano-Technology, Inc. (PCNT)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -78.01 Thousand USD | -22.84% |
| 2022 | -63.51 Thousand USD | -746.87% |
| 2021 | -7500.00 USD | 41.13% |
| 2020 | -12.74 Thousand USD | 0.0% |
| 2015 | -118.78 Million USD | -64064.84% |
| 2014 | -185.12 Thousand USD | -57.09% |
| 2013 | -117.84 Thousand USD | 21.03% |
| 2012 | -149.22 Thousand USD | 74.15% |
| 2011 | -577.29 Thousand USD | -171.74% |
| 2010 | -212.44 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -78.02 Thousand USD | -22.84% |
| 2023 Q4 | -27.02 Thousand USD | -176.48% |
| 2023 Q3 | -9773.00 USD | 25.71% |
| 2023 Q2 | -13.15 Thousand USD | -34.61% |
| 2023 Q1 | -9773.00 USD | 25.71% |
| 2022 Q4 | -13.15 Thousand USD | -125.37% |
| 2022 FY | -63.51 Thousand USD | -746.87% |
| 2022 Q1 | -42.25 Thousand USD | -463.4% |
| 2022 Q2 | -13.79 Thousand USD | 67.35% |
| 2022 Q3 | -5837.00 USD | 57.69% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q4 | -7500.00 USD | 0.0% |
| 2021 FY | -7500.00 USD | 41.13% |
| 2021 Q3 | - USD | 0.0% |
| 2020 FY | -12.74 Thousand USD | 0.0% |
| 2015 Q3 | -118.27 Million USD | -282894.29% |
| 2015 Q2 | -41.79 Thousand USD | 87.68% |
| 2015 Q1 | -339.25 Thousand USD | -711.31% |
| 2015 FY | -118.78 Million USD | -64064.84% |
| 2015 Q4 | -126.27 Thousand USD | 99.89% |
| 2014 FY | -185.12 Thousand USD | -57.09% |
| 2014 Q4 | -41.81 Thousand USD | 17.08% |
| 2014 Q2 | -62.27 Thousand USD | -103.47% |
| 2014 Q1 | -30.6 Thousand USD | -28.66% |
| 2014 Q3 | -50.42 Thousand USD | 19.02% |
| 2013 Q1 | -40.03 Thousand USD | -37.89% |
| 2013 FY | -117.84 Thousand USD | 21.03% |
| 2013 Q3 | -23.4 Thousand USD | 23.54% |
| 2013 Q2 | -30.61 Thousand USD | 23.54% |
| 2013 Q4 | -23.78 Thousand USD | -1.63% |
| 2012 Q3 | -35.19 Thousand USD | 0.52% |
| 2012 Q4 | -29.03 Thousand USD | 17.5% |
| 2012 FY | -149.22 Thousand USD | 74.15% |
| 2012 Q1 | -49.6 Thousand USD | 18.45% |
| 2012 Q2 | -35.38 Thousand USD | 28.68% |
| 2011 Q1 | -439.84 Thousand USD | 0.0% |
| 2011 Q2 | -23.97 Thousand USD | 94.55% |
| 2011 Q3 | -52.64 Thousand USD | -119.59% |
| 2011 Q4 | -60.82 Thousand USD | -15.54% |
| 2011 FY | -577.29 Thousand USD | -171.74% |
| 2010 FY | -212.44 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| America Great Health | -492.64 Thousand USD | 84.164% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | 99.18% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | 99.74% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 99.884% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | 99.508% |
| Better Therapeutics, Inc. | -38.26 Million USD | 99.796% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 99.815% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | 99.348% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | 99.769% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | 99.773% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 99.928% |
| Evolutionary Genomics, Inc. | -2.01 Million USD | 96.127% |
| Finch Therapeutics Group, Inc. | -34 Million USD | 99.771% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 99.834% |
| Innovation1 Biotech Inc. | -1.36 Million USD | 94.294% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | 99.609% |
| Molecular Templates, Inc. | -10.46 Million USD | 99.255% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | 99.445% |
| NexImmune, Inc. | -29.19 Million USD | 99.733% |
| Orgenesis Inc. | -53.63 Million USD | 99.855% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 99.848% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 99.517% |
| Scopus BioPharma Inc. | -11.71 Million USD | 99.334% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 99.985% |
| Statera Biopharma, Inc. | -98.34 Million USD | 99.921% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | 98.869% |
| Trevena, Inc. | -35.28 Million USD | 99.779% |
| Vaxxinity, Inc. | -58.28 Million USD | 99.866% |
| Vaccinex, Inc. | -22.88 Million USD | 99.659% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | 92.548% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 99.846% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 98.926% |